-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

112. Thalassemia and Globin Gene Regulation: Poster III

Thalassemia and Globin Gene Regulation Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

M Domenica Cappellini1, Vip Viprakasit2, Yesim Aydinok3, John B Porter4*, Yong-Rong Lai5*, Noppadol Siritanaratkul2, Zeynep Karakas6*, Antonis Kattamis7, Candace Wang8*, Zewen Zhu8*, Felicity Schaefer8* and Ali T Taher9

1Universitá di Milano, Ca Granda Foundation IRCCS, Milan, Italy
2Department of Pediatrics and Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
3Ege University Hospital, Izmir, Turkey
4University College London, London, United Kingdom
5The First Affiliated Hospital of Guangxi Medical University, Nanning, China
6Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey
7First Dept of Pediatrics, University of Athens, Athens, Greece
8Novartis Pharmaceuticals, East Hanover, NJ
9American University of Beirut Medical Center, Beirut, Lebanon

Alessia Pepe1*, Antonella Meloni1*, Maria Giovanna Neri1*, Massimo Allò2*, Elena Facchini3*, Tommaso Casini4*, Aurelio Maggio, MD5, Vincenzo Positano6*, Gianluca Valeri7*, Elisabetta Chiodi8*, Cristina Salvatori9* and Maria Rita Gamberini10*

1CMR Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
2Servizio Microcitemia, Presidio Ospedaliero ASL 5, Crotone, Italy
3U.O. di Pediatria -Prof A. Pession, Azienda Ospedaliero-Universitaria di bologna - Policlinico "S. Orsola-MalpighiBologna - Policlinico S. Orsola-Malpighi", Bologna, Italy
4Centro Talassemie ed Emoglobinopatie, Ospedale Meyer, Firenze, Italy
5Unità Operativa Complessa Ematologia II, A.O.R. “Villa Sofia – V. Cervello’’, Palermo, Italy
6Unità Operativa Complessa Ematologia con Talassemia, “ARNAS” Civico, Palermo, Italy
7Dipartimento di Radiologia, Azienda Ospedaliero-Universitaria Ospedali Riuniti "Umberto I-Lancisi-Salesi", Ancona, Italy
8Servizio Radiologia Ospedaliera-Universitaria, Arcispedale “S.Anna”, Ferrara, Italy
9Unità Operativa Sistemi Informatici, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
10Pediatria, Adolescentologia e Talassemia, Arcispedale “S.Anna”, Ferrara, Italy

Debmalya Bhattacharyya1*, Maitreyee Bhattacharyya, DM1, Saswata Chatterjee2*, Abhijit Chowdhury2* and Pramit Ghosh3*

1Institute of Haematology and Transfusion Medicine,Medical College, Kolkata, India
2School of Digestive and Liver Diseases, IPGMER, Kolkata, India
3Department of Community Medicine, Medical College, Kolkata, India

Andrea Jarisch, MD1*, Regine Grosse, MD2*, Emilia Salzmann-Manrique3*, Roland Fischer, PhD4*, Jan Soerensen, MD3*, Renate Hammerstingl, MD5*, Eva Rettinger, MD3*, Andre Manfred Willasch, MD6*, Thomas Klingebiel, MD7 and Peter Bader, MD8

1Division for Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt am Main, Germany
2University Medical Center Hamburg-Eppendorf/Pediatric and Adult Hematology and Oncology, University, Hamburg, Germany
3Division for Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany
4University Medical Center Hamburg-Eppendorf/Pediatric Hematology and Oncology, University, Hamburg, Germany
5Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany
6Division for Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt Am Main, Germany
7Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital Frankfurt, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany
8Division for Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University of Frankfurt, Frankfurt, Germany

Pierre-Olivier Gaudreau, M.D., M.Ps., FRCPC1*, Xiaoduan Weng, M.D., Ph.D.1*, Marilyn Brillant, T.M.1*, Michael Newmarch, M.D.2, Guillaume Lettre, Ph.D.3*, Michele Mahone, M.D., FRCPC4*, Florence Weber, M.D., FRCPC4*, Marie-Josee Bedard, M.D., FRCSC5*, Andre Masse, M.D., FRCSC5*, John Stagg, Ph.D.6*, Vincent-Philippe Lavallee, M.D.7 and Denis Soulieres, MD, FRCPC, MSc1

1Hematology and Medical Oncology, Notre-Dame Hospital (CHUM), Montreal, QC, Canada
2Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
3Montreal Heart Institute, Universite de Montreal, Montreal, QC, Canada
4Internal Medicine, Saint-Luc Hospital (CHUM), Montreal, QC, Canada
5Obstetrics and Gynecology, Saint-Luc Hospital (CHUM), Montreal, QC, Canada
6CHUM Research Center (CRCHUM), Montreal, QC, Canada
7Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada

N. Scott Reading, Ph.D.1,2,3*, Barnaby E. Clark, Ph.D.4*, Jihyun Song, MS2*, Claire C. Shooter5*, Robin E. Miller, M.D.6, Archana M Agarwal, M.D.3*, Swee Lay Thein, M.D.7,8, Vladimir Divoky, PhD9 and Josef T. Prchal, M.D.1,10,11

1Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT
2Division of Hematology, School of Medicine, University of Utah, Salt Lake City, UT
3Department of Pathology, University of Utah, Salt Lake City, UT
4Department of Molecular Pathology, Viapath at King's College Hospital, London, United Kingdom
5Molecular Haematology, Division of Cancer Studies, King's College London, London, United Kingdom
6Nemours Center for Cancer and Blood Disorders, Nemours/Al duPont Hospital for Children, Wilmington, DE
7Molecular Haematology, Division of Cancer Studies, Kings College London, London, United Kingdom
8National Heart, Lung and Blood Institute, Sickle Cell Branch, National Institutes of Health, Bethesda, MD
9Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
10Division of Hematology, University of Utah, Salt Lake City, UT
11Department of Medicine, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT

Daniel Garcia dos Santos, PhD1*, Zuzana Zidova, MSc2*, Marc Mikhael, PhD3*, Amel Hamdi, PhD4*, Monika Horvathova, PhD5 and Prem Ponka, MD, PhD, FCMA1

1Lady Davis Institute for Medical Research, Montreal, QC, Canada
2Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
3School of Arts and Science, Lebanese American University, Beirut, Lebanon
4Department of Physiology and Medicine, McGill University, Montreal, QC, Canada
5Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

Molly Susan Hein, BS1*, Jennifer L Oliveira, MD1, Kenneth C Swanson, MT(ASCP)1*, Patrick A Lundquist, MB(ASCP), CG(ASCP)2*, Joella A Yungerberg, MLS(ASCP)1*, Lea M Coon, MS1*, Brian D Dawson, PhD2*, Ronald S. Go, MD3, Dragan Jevremovic, MD PhD1* and James D Hoyer, MD1

1Hematopathology and Metabolic Hematology Laboratory, Mayo Clinic, Rochester, MN
2Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN

Barnaby E. Clark, Ph.D.1,2*, Claire C. Shooter2*, Frances Smith1*, David Brawand1*, Laura Steedman1*, Matthew Oakley1*, Peter Rushton1*, Helen Rooks3*, Xunde Wang, PhD4*, Anthi Drousiotou5*, Andriani Kyrri6*, Xenia Felekis5*, Miranda Petrou5*, Andrew M Will, MD7*, Chris Fisher, Ph.D.8*, Douglas R. Higgs, FRS8, Cornelius Harteveld9*, Marion Phylipsen9*, Marina Kleanthous, PhD5* and Swee Lay Thein, MD, DSc2,10

1Department of Molecular Pathology, Viapath at King's College Hospital, London, United Kingdom
2Molecular Haematology, Division of Cancer Studies, King's College London, London, United Kingdom
3Molecular Haematology, King’s College London, London, United Kingdom
4Sickle Cell Vascular Disease Section, Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD
5The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
6Thalassaemia Center, Nicosia, Cyprus
7Paediatric Haematology, Royal Manchester Children’s Hospital, Manchester, United Kingdom
8MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford, United Kingdom
9Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands
10National Heart, Lung and Blood Institute, Sickle Cell Branch, National Institutes of Health, Bethesda, MD

Ciaran Lee, PhD1*, Gang Bao, PhD1*, Matthew H. Porteus, MD, PhD2, Tatjana Cornu, PhD3*, Annarita Miccio, PhD4,5*, Thomas Cradick6*, Toni Cathomen, PhD3*, Ante Lundberg, MD7 and Fulvio Mavilio, PhD4*

1Rice University, Houston, TX
2Department of Pediatrics, Cancer Biology, Stanford University School of Medicine, Stanford, CA
3University Medical Center Freiburg, Freiburg, Germany
4Genethon, Evry, France
5Imagine Institute, Paris, France
6CRISPR Therapeutics, Boston, MA
7CRISPR THERAPEUTICS, CAMBRDIGE, MA

Carolina A Braghini, MSc1,2*, Fernando F Costa, PhD, MD2, Flavia C Costa, PhD3*, Halyna Fedosyuk, MS1*, Matthew Parker, BS1*, Allen M Chazelle, MS1* and Kenneth R Peterson, PhD1,4

1Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS
2Hematology and Hemotherapy Center, University of Campinas - SP, Sao Paulo, Brazil
3Kansas Biosciences Authority, Olathe, KS
4Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS

Jeffrey R Shearstone, PhD1, Apurva Chonkar, MS1*, Kailash Bhol, PhD1*, Simon S Jones, PhD2* and Matt Jarpe, PhD1*

1Acetylon Pharmaceuticals, Inc., Boston, MA
2Acetylon Pharmaceuticals, Inc., Boston

*signifies non-member of ASH